BOUNDLESS BIO, INC. (BOLD) Capital expenditures 2023–2025
BOUNDLESS BIO, INC. (BOLD) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$546,000FY2025 · since FY2023: $633,000 → $546,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $546,000 | -78.5% |
| FY2024 | $2.5M | +300.6% |
| FY2023 | $633,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice